Berry Lance A
SEC CIK 1478716 · EDGAR
BoughtSold
Most active insiders at AORT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mackin James P | Pres, CEO | — | $9.72M |
| 2 | Stanton Marshall S. | SVP, Clinical, MD Affair | — | $3.43M |
| 3 | Holloway Jean F | SVP, GC | — | $2.54M |
| 4 | Davis John E | Chief Commercial Off | — | $1.75M |
| 5 | GREEN ANDREW M | SVP, Regulatory, Quality | — | $1.43M |
| 6 | Horton Amy | VP, CAO | — | $870.1K |
| 7 | Berry Lance A | EVP, COO, CFO, Treas | — | $803.2K |
| 8 | Hoff Elizabeth A | Dir | — | $189.4K |
| 9 | SEMEDO ANTHONY B. | Dir | — | — |
| 10 | Borgstrom Marna P | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-17 15:17 | 2026-08-14 | AORT | ARTIVION, INC. | Berry Lance A | EVP, COO, CFO, Treas | S - Sale | $28.55 | -715 | 210.1K | -0.3% | -$20.4K | |
| 2026-05-19 21:00 | 2026-05-19 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Berry Lance A | Dir | A - Grant | $0.00 | +30.0K | 74.6K | +67% | $0 | |
| 2026-03-04 | 2026-03-02 | AORT | ARTIVION, INC. | Berry Lance A | EVP, COO, CFO, Treas | A - Grant | $0.00 | +40.9K | 217.1K | +23% | $0 | |
| 2026-03-04 | 2026-03-03 | AORT | ARTIVION, INC. | Berry Lance A | EVP, COO, CFO, Treas | S - Sale | $37.78 | -6,316 | 210.8K | -3% | -$238.6K | |
| 2026-03-03 | 2026-03-02 | AORT | ARTIVION, INC. | Berry Lance A | EVP, COO, CFO, Treas | S - Sale | $38.02 | -5,178 | 176.3K | -3% | -$196.9K | |
| M | 2026-02-25 | 2026-02-23+ | AORT | ARTIVION, INC. | Berry Lance A | EVP, COO, CFO, Treas | S - Sale | $36.69 | -9,466 | 144.0K | -6% | -$347.3K |
| 2026-02-25 | 2026-02-24 | AORT | ARTIVION, INC. | Berry Lance A | EVP, COO, CFO, Treas | A - Grant | $0.00 | +37.5K | 181.4K | +26% | $0 | |
| 2025-05-21 | 2025-05-20 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Berry Lance A | Dir | A - Grant | $0.00 | +23.9K | 44.6K | +116% | $0 | |
| 2025-03-10 | 2025-03-06 | AORT | ARTIVION, INC. | Berry Lance A | CFO, Executive VP | S - Sale | $24.80 | -4,909 | 153.4K | -3% | -$121.7K | |
| 2025-03-10 | 2025-03-06 | AORT | ARTIVION, INC. | Berry Lance A | CFO, Executive VP | A - Grant | $0.00 | +48.1K | 158.3K | +44% | $0 | |
| 2025-03-04 | 2025-02-28 | AORT | ARTIVION, INC. | Berry Lance A | CFO, Executive VP | A - Grant | $0.00 | +34.4K | 110.2K | +45% | $0 | |
| 2025-02-26 | 2025-02-24 | AORT | ARTIVION, INC. | Berry Lance A | CFO, Executive VP | S - Sale | $27.31 | -3,259 | 75.8K | -4% | -$89.0K | |
| D | 2024-05-22 | 2024-05-21 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Berry Lance A | Dir | A - Grant | $0.00 | +15.1K | 20.7K | +270% | $0 |
| 2024-02-26 | 2024-02-23 | AORT | ARTIVION, INC. | Berry Lance A | CFO, Executive VP | A - Grant | $0.00 | +37.0K | 79.1K | +88% | $0 | |
| D | 2023-12-08 | 2023-12-06 | AORT | ARTIVION, INC. | Berry Lance A | CFO, Executive VP | A - Grant | $17.83 | +42.1K | 42.1K | New | +$750.0K |
| D | 2023-05-25 | 2023-05-23 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Berry Lance A | Dir | A - Grant | $0.00 | +2,753 | 5,585 | +97% | $0 |
| D | 2022-10-04 | 2022-10-01 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Berry Lance A | Dir | A - Grant | $0.00 | +2,832 | 2,832 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations